Viewing Study NCT02217566


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT02217566
Status: COMPLETED
Last Update Posted: 2020-01-13
First Post: 2014-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostatic neoplasms View
None Diethylstilbestrol therapy View
None Abiraterone acetate View
None Prednisone View
None Androgen deprivation therapy View